Advertisement

Causes and Management of Ascites

  • L. M. Blendis
Part of the Topics in Gastroenterology book series (TGEN)

Abstract

Ascites is a major complication of cirrhosis, the other two complications being variceal hemorrhage and portasystemic encephalopathy. Yet it receives relatively little attention in the literature, being mistakenly regarded as less of a threat to life. Although the patient with bleeding varices and encephalopathy can present more dramatically, ascites and edema represent as great, if not more insidious, a threat to life. Indeed, Powell and Klatskin1 showed that the appearance of ascites in a cirrhotic patient was associated with a significantly reduced 5-year survival rate.

Keywords

Plasma Renin Activity Renal Blood Flow Ascitic Fluid Spontaneous Bacterial Peritonitis Hepatorenal Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Powell WJ, Klatskin G. Duration of survival in patients with alcoholic cirrhosis. Influence of alcohol withdrawal and possible effects of recent changes in management of the disease. Am J Med 1968;44:406–412.PubMedCrossRefGoogle Scholar
  2. 2.
    Orrego H, Israel Y, Blake JE, Medline A. Assessment of prognostic factors in alcoholic liver disease; toward a global quantitative expression of severity. Hepatology 1983;3:896–905.PubMedCrossRefGoogle Scholar
  3. 3.
    Crossley IR, Williams R. Spontaneous bacterial peritonitis. Gut 1985;26:325–331.PubMedCrossRefGoogle Scholar
  4. 4.
    Levy M. Hepatorenal syndrome. In: The Kidney: Physiology and Pathophysiology (Seldin DW, Giebisch G, ed). New York: Raven Press, 1985, pp. 1945–1961.Google Scholar
  5. 5.
    Eckardt VF, Grace ND, Kantrowitz PA. Does lower esophageal sphincter incompetency contribute to esophageal variceal bleeding? Gastroenterology 1976;71:185–189.PubMedGoogle Scholar
  6. 6.
    Lill SR, Parsons RH, Buhac I. Permeability of the diaphragm and fluid resorption from the peritoneal cavity in the rat. Gastroenterology 1979;76:997–1001.PubMedGoogle Scholar
  7. 7.
    Better OS, Sender RW. Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int 1983;23:303–311.PubMedCrossRefGoogle Scholar
  8. 8.
    Epstein FH, Lesser GT, Berger EY. Renal function in decompensated cirrhosis of the liver. Proc Soc Exp Bio Med 1950;75:822–824.Google Scholar
  9. 9.
    Klinger EL, Vaamonde CA, Vaamonde LS, Lancastremere RG, Morosi HJ, Frisch E, Papper S. Renal function changes in cirrhosis of the liver, a prospective study. Arch Intern Med 1970;125:1010–1015.CrossRefGoogle Scholar
  10. 10.
    Wilkinson SP, Jowett TP, Slater JDH, Arroya V, Moddie H, Williams R. Renal sodium retention in cirrhosis: Relation to aldosterone and nephron site. Clin Sci 1979;56:169–177.PubMedGoogle Scholar
  11. 11.
    Wernze H, Spectz HG, Muller G. Studies on the activity of the renin-angiotensin-aldosterone system (RAAs) in patients with cirrhosis of the liver. Klin Wochensch 1978;56:389–397.CrossRefGoogle Scholar
  12. 12.
    Bernardi M, Trevisani F, Santini C, De Palma R, Gasbarrini G. Aldosterone related blood volume expansion in cirrhosis before and after the early phase of ascites formation. Gut 1983;24:761–766.PubMedCrossRefGoogle Scholar
  13. 13.
    Levy M. Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am J Physiol 1977;233F:572–585.Google Scholar
  14. 14.
    Levy M, Allotey JBK. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J Lab Clin Med 1978;92:560–569.PubMedGoogle Scholar
  15. 15.
    Unikowsky B, Wexler MJ, Levy M. Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites. J Clin Invest 1983;1594–1604.Google Scholar
  16. 16.
    Campbell V, Greig PD, Cranford J, Langer B, Silverman M, Blendis LM. A comparison of acute reversible pre and post sinusoidal portal hypertension on salt and water retention in the dog. Hepatology 1982;2:54–58.PubMedCrossRefGoogle Scholar
  17. 17.
    Kostreva DR, Castaner A, Kampine JP. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nerve activity. Am J Physiol 1980;238:R390–R395.PubMedGoogle Scholar
  18. 18.
    Cherrick GR, Kerr DNS, Read AE, Sherlock S. Colloid osmotic pressure and hydrostatic pressure relationships in the formation of ascites in hepatic cirrhosis. Clin Sci 1960;19:361–375.PubMedGoogle Scholar
  19. 19.
    Witte MH, Witte CL, Dumont AE. Progress in liver disease; physiological factors involved in the causation of cirrhotic ascites. Gastroenterology 1971;61:742–750.PubMedGoogle Scholar
  20. 20.
    Coppage WS, Island DP, Cooner AE, Liddle GW. The metabolism of aldosterone in normal subjects and in patients with hepatic cirrhosis. J Clin Invest 1962;41:1672–1680.PubMedCrossRefGoogle Scholar
  21. 21.
    Epstein M. Renal effects of head-out water immersion in man. Implications for an understanding of volume homeostasis. Physiol Rev 1978;58:529–581.PubMedGoogle Scholar
  22. 22.
    Epstein M, Levinson R, Sancho J, Haber E, Re R. Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res 1977;41:818–829.PubMedGoogle Scholar
  23. 23.
    Epstein M, Pins DS, Schneider N, Levinsion R. Determinants of deranged sodium and water homeostasis in decompensated cirrhosis. J Lab Clin Med 1976;87:822–839.PubMedGoogle Scholar
  24. 24.
    Nicholls KM, Shapiro MD, Kluge R, Chung HM, Bichet DG, Schrier RW. Sodium excretion in advanced cirrhosis: Effect of expansion of central blood volume and suppression of plasma aldosterone. Hepatology 1986;6:235–238.PubMedCrossRefGoogle Scholar
  25. 25.
    Blendis LM, Greig PD, Langer B, Baigrie RS, Ruse J, Taylor BR. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites. Gastroenterology 1979;77:250–257.PubMedGoogle Scholar
  26. 26.
    Greig PD, Blendis LM, Langer B, Taylor BR, Colapinto RF. Renal and hemodynamic effects of the peritoneovenous shunt. II. Long term effects. Gastroenterology 1981;80:119–125.PubMedGoogle Scholar
  27. 27.
    Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, Merrill JP. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970;49:175–185.PubMedCrossRefGoogle Scholar
  28. 28.
    Barnardo DE, Baldus WP, Maher FT. Effects of dopamine on renal function in patients with cirrhosis. Gastroenterology 1970;58:524–531.PubMedGoogle Scholar
  29. 29.
    Koppel MH, Coburn JW, Mims MM, Goldstein H, Boyle JD, Rubini ME. Transplant of cadaveric kidneys from patients with hepatorenal syndrome. N Engl J Med 1969;280:1367–1371.PubMedCrossRefGoogle Scholar
  30. 30.
    Kew MC, Brunt PW, Varma RR, Hourigan KJ, Williams HS, Sherlock S. Renal and intrarenal blood flow in cirrhosis of the liver. Lancet 1971;2:504–509.PubMedCrossRefGoogle Scholar
  31. 31.
    Ring-Larsen H. Renal blood flow in cirrhosis; relation to systemic and portal hemodynamics and liver function. Scand J Clin Lab Invest 1977;37:635–642.PubMedCrossRefGoogle Scholar
  32. 32.
    Epstein M. Schneider N, Befeler B. Relationship of systemic and intrarenal hemodynamics in cirrhosis. J Lab Clin Med 1977;89:1175–1187.PubMedGoogle Scholar
  33. 33.
    Stein JH, Mauk RC, Boonjarern S, Ferris T. Differences in the effect of furosemide and chlorothiazide on the distribution of renal cortical blood flow in the dog. J Lab Clin Med 1972;79:995–1003.PubMedGoogle Scholar
  34. 34.
    Stein JH, Boonjarern S, Wilson CB, Ferris TF. Alterations in intrarenal blood flow distribution. Methods of measurement and relationship to sodium balance. Circ Res 1973;32–33 (Suppl. 1) 61–72.Google Scholar
  35. 35.
    DiBona GF. Neurogenic regulation of renal tubular sodium re-absorption. Am J Physiol 1977;233:F73–F81.PubMedGoogle Scholar
  36. 36.
    Ring-Larsen H, Hesse B, Henriksen JH, Christensen NJ. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: Plasma norepinephrine concentration, hepatic extraction and renal release. Hepatology 1982;2:304–310.PubMedCrossRefGoogle Scholar
  37. 37.
    Bichet DG, VanPutten VH, Schrier RW. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982;307:1552–1557.PubMedCrossRefGoogle Scholar
  38. 38.
    Willet I, Esler M, Burke F. Total and renal sympathetic nervous activity in alcoholic cirrhosis. J Hepatol 1985;1:639–648.CrossRefGoogle Scholar
  39. 39.
    Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest 1953;32:1025–1033.PubMedCrossRefGoogle Scholar
  40. 40.
    Lunzer MR, Manghani KK, Newman SP, Sherlock S, Bernard AG, Ginsburg J. Impaired cardiovascular responsiveness in liver disease. Lancet 1975;2:382–389.PubMedCrossRefGoogle Scholar
  41. 41.
    Finberg JPM, Syrop HA, Better OS. Blunted pressor response to angiotensin and sympathomimetic amines in the bile duct ligated dogs. Clin Sci 1981;61:535–359.PubMedGoogle Scholar
  42. 42.
    Bomzon A, Rosenberg M, Gali D, Binah O, Mordechovitz D, Better OS, Greig PD, Blendis LM. Systemic hypotension and decreased pressor response in dogs with chronic bile duct ligation. Hepatology 1986;6:595–600.PubMedCrossRefGoogle Scholar
  43. 43.
    Lunzer MR, Newman SP, Sherlock S. Skeletal muscle blood flow and neurovascular reactivity in liver disease. Gut 1973;14:354–359.PubMedCrossRefGoogle Scholar
  44. 44.
    Gerbes AL, Remien J, Jungst D, Saverbruch T, Daum Gartner G. Evidence for down regulation of beta-2-adrenoreceptors in cirrhotic patients with severe ascites. Lancet 1986; 1:1409–1411.PubMedCrossRefGoogle Scholar
  45. 45.
    Bernardi M, Trevisani F, Landini C. Plasma norepinephrine, weak neurotransmitters and renin activity during active tilting in liver cirrhosis: Relationship with cardiovascular homeostasis and renal function. Hepatology 1983;3:56–64.PubMedCrossRefGoogle Scholar
  46. 46.
    Nicholls KM, Shapiro MD, VanPutten VJ. Elevated plasma norepinephrine concentrations in decompensated cirrhosis: Association with increased secretion rates, normal clearance rates and suppressibility by central blood volume expansion. Circ Res 1985;56:457–461.PubMedGoogle Scholar
  47. 47.
    Bichet D, Groves B, Schrier RW. Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients. Kidney Int 1983;24:788–794.PubMedCrossRefGoogle Scholar
  48. 48.
    Epstein M, Larios O, Johnson G. Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Min Electr Metab 1985;11:25–34.Google Scholar
  49. 49.
    Blendis LM, Sole MJ, Campbell P, Lossing AG, Greig PD, Taylor BR, Langer B. The effect of peritoneovenous shunting on catecholamine metabolism in patients with hepatic ascites. Hepatology 1987;1:143–148.CrossRefGoogle Scholar
  50. 50.
    Bichet DG, Szatalowicz V, Chaimovitz C, Schrier RW. Role of vasopressin in abnormal water excretion in cirrhotic humans. Ann Intern Med 1982;96:413–417.PubMedGoogle Scholar
  51. 51.
    Epstein M, Weitzman RE, Preston S, Denunzio AG. Role of ADH as a determinant of impaired excretion in patients with decompensated cirrhosis (abstr). Clin Res 1982;30:539.Google Scholar
  52. 52.
    Reznick RK, Langer B, Taylor BR, Greig PD, Blendis LM. Hyponatremia and arginine vasopressin secretion in patients with refactory ascites undergoing peritoneovenous shunting. Gastroenterology 1983;84:713–718.PubMedGoogle Scholar
  53. 53.
    Dunn MJ, Hood VL. Prostaglandins and the kidney. Am J Physiol 1977;233:F169–F184.Google Scholar
  54. 54.
    Lonigro AJ, Itskovitz HD, Crowshaw K, McGriff JC. Dependency of renal blood flow on protaglandin synthesis in the dog. Circ Res 1973;32:712–717.PubMedGoogle Scholar
  55. 55.
    Boyer TD, Zia PK, Reynolds TB. Effect of indomethacin and prostaglandin A on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 1979;77:215–222.PubMedGoogle Scholar
  56. 56.
    Zipser RD. The role of renal prostaglandins and the effects of nonsteroidal anti-inflammatory drugs in patients with liver disease. Am J Med 1986;81:(Suppl 28) 95–103.PubMedCrossRefGoogle Scholar
  57. 57.
    Epstein M, Lifschitz M, Ramachandran M, Rappaport K. Characterization of renal prostaglandin E responsiveness in decompensated cirrhosis: Implications for renal sodium handling. Clin Sci 1982;62:555–563.Google Scholar
  58. 58.
    Shaw-Stiffel T, Campbell PJ, Sole MJ, Greig P, Wong PY, Blendis LM. Renal prostaglandin E2 and other vasoactive modulators in refractory hepatic ascites; response to peritoneovenous shunting. Gastroenterology 1988.Google Scholar
  59. 59.
    DeBold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89–94.CrossRefGoogle Scholar
  60. 60.
    Sonnenberg H. Mechanisms of release and renal tubular action of atrial natriuretic factor. Fed Proc 1986;45:2106–2110.PubMedGoogle Scholar
  61. 61.
    Winquist RJ, Faison EP, Walman SA, Schwartz K, Murad F, Rapoport RM. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate granylate cylase in vascular smooth muscle. Proc Natl Acad Sci USA 1984;7661–7664.Google Scholar
  62. 62.
    Maack T, Atlas SA, Camargo MJF, Cogan MG. Renal hemodynamics and natriuretic effects of atrial natriuretic factor. Fed Proc 1986;45:2128–2132.PubMedGoogle Scholar
  63. 63.
    Shenker Y, Sider RS, Ostafin A, Grekin RJ. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985;76:1681–1687.Google Scholar
  64. 64.
    Fernandez-Gruz A, Marco J, Cuadrado ML. Plasma levels of atrial natriuretic peptide in cirrhotic patients. Lancet 1985;1:1439–1440.CrossRefGoogle Scholar
  65. 65.
    Gines P, Jimenez W, Narasa M, Sanz G, Tito LL, Lopez C, Rivera F, Arroya V, Rodes J. Atrial natriuretic factor (ANF) in cirrhosis plasma levels, cardiac release and splanchnic extraction. J Hepatol 1986;3 (Suppl.):S30.Google Scholar
  66. 66.
    Campbell PJ, Skorecki KL, Logan AG, Wong PY, Leung WM, Grieg P, Blendis LM. The acute effects of peritoneovenous shunting (PVS) on plasma atrial natriuretic peptide in cirrhotics with massive refractory ascites. Am J Med 1988;84:112–119.PubMedCrossRefGoogle Scholar
  67. 67.
    Yamada S, Reynolds TB. Amiloride (MK-870). A new antikaluretic diuretic. Gastroenterology 1970;59:833–841.PubMedGoogle Scholar
  68. 68.
    Campra JL, Reynolds TB. Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites. Dig Dis 1978;23:1025–1030.CrossRefGoogle Scholar
  69. 69.
    Shear L, Ching S, Gabuzda G. Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med 1970;282:1391–1396.PubMedCrossRefGoogle Scholar
  70. 70.
    Perez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodes J. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology 1983;84:961–968.PubMedGoogle Scholar
  71. 71.
    Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. Br Med J 1936;292:1351–1353.CrossRefGoogle Scholar
  72. 72.
    Sherlock S, Senewirantne B, Scott A, Walker JG. Complications of diuretic therapy in hepatic cirrhosis. Lancet 1966;1:1049–1052.PubMedCrossRefGoogle Scholar
  73. 73.
    Lowenthal DT, Sherar L. Use of a new diuretic agent (Metolazone) in patients with edema and ascites. Arch Intern Med 1973;132:38–42.PubMedCrossRefGoogle Scholar
  74. 74.
    Kao HW, Rakov NE, Savage E, Reynolds TB. The effect of large volume paracentesis on plasma volume: A cause of hypovolemia. Hepatology 1985;5:403–407.PubMedCrossRefGoogle Scholar
  75. 75.
    Simon DM, McCain JR, Bonkovsky HL, Wells JO, Hartle DK, Galambos JT. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology 1987;7:423–429.PubMedCrossRefGoogle Scholar
  76. 76.
    Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jimenez W, Mastai R, Gaya J, Rodes J. Comparison of paracentesis and diuretics in treatment of cirrhotics with tense ascites. Gastroenterology 1987;93:234–241.PubMedGoogle Scholar
  77. 77.
    Harmon DC, Demirzian Z, Ellman L, Fisher JE. Disseminated intravascular coagulation with the peritoneovenous shunt. Ann Intern Med 1979;90:774–779.PubMedGoogle Scholar
  78. 78.
    Greig PD, Langer B, Blendis LM, Taylor BR, Glynn MFX. Complications after peritoneovenous shunting for ascites. Am J Surg 1980;139:125–131.PubMedCrossRefGoogle Scholar
  79. 79.
    Salem HH, Dudley FJ, Merrett A, Perkin J, Firkin BG. Coagulopathy of peritoneovenous shunt. Studies on the pathogenic role of ascitic fluid collagen and value of anti-platelet therapy. Gut 1983;24:412–417.PubMedCrossRefGoogle Scholar
  80. 80.
    Blendis LM, Harrison JE, Russell KM, Miller C, Taylor BR, Greig PD, Langer B. The effects of peritoneovenous shunting on body composition. Gastroenterology 1986;90:127–134.PubMedGoogle Scholar
  81. 81.
    Blendis LM. Le Veen vs. Denver. Peritoneovenous shunts: Inadequate numbers of techniques? Mini-editorial. Hepatology 1987;7:405–406.CrossRefGoogle Scholar
  82. 82.
    Crossley IR, Williams R. Spontaneous bacterial peritonitis. Gut 1985;26:325–331.PubMedCrossRefGoogle Scholar
  83. 83.
    Hoefs JC, Canawti HN, Sapico FL, Hokins RR, Weiner J, Montgomerie JZ. Spontaneous bacterial peritonitis. Hepatology 1982;2:399–407.PubMedCrossRefGoogle Scholar
  84. 84.
    Pinzello G, Simonetti RG, Craxi A, de Piazza S, Spano C, Pagliaro L. Spontaneous bacterial peritonitis: A prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 1983;3:545–549.PubMedGoogle Scholar
  85. 85.
    Bar-Meir S, Lerner E, Conn HO. Analysis of ascitic fluid in cirrhosis. Dig Dis Sci 1979;24:136–144.Google Scholar
  86. 86.
    Gitline N, Stauffer JL, Silverstri RC. The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis. Hepatology 1982;4:408–411.Google Scholar
  87. 87.
    Scemama-Clergue J, Doutrellet-Phillipon C, Metreau JM, Tessiere B, Capron D, Dhumeaux D. Ascitic fluid pH in alcoholic cirrhosis: A re-evaluation of its use in the diagnosis of spontaneous bacterial peritonitis. Gut 1985;26:332–335.PubMedCrossRefGoogle Scholar
  88. 88.
    Garcia-Tsao G, Conn HO, Lerner E. The diagnosis of spontaneous bacterial peritonitis: Comparison of pH, lactate concentration and leucocyte count. Hepatology 1985;5:91–96.PubMedCrossRefGoogle Scholar
  89. 89.
    Brook I, Altmann RS, Loebman WW, Seef LB. Measurement of lactate in ascitic fluid. An aid to the diagnosis of peritonitis with particular reference to spontaneous bacterial peritonitis of the cirrhotic. Dig Dis Sci 1981;26:1089–1094.PubMedCrossRefGoogle Scholar
  90. 90.
    Runyon BA, Hoefs JC. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984;4:1209–1211.PubMedCrossRefGoogle Scholar
  91. 91.
    Cohn JN, Tristani FE, Khatri IM. Renal vasodilator therapy in the hepatorenal syndrome. Med DC 1970;39:1–7.Google Scholar
  92. 92.
    Fullen WD. Hepatorenal syndrome: Reversal by peritoneovenous shunt. Surgery 1977;82:337–341.PubMedGoogle Scholar
  93. 93.
    Schroeder ET, Anderson GH, Smulyan H. Effects of a portocaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney Int 1979;15:54–61.PubMedCrossRefGoogle Scholar
  94. 94.
    Kinney MJ, Schneider A, Wapnick S, Grosberg S, Le Veen H. The hepatorenal syndrome and refractory ascites. Nephron 1979;23:228–232.PubMedCrossRefGoogle Scholar
  95. 95.
    Lina S, Schaefer JW, Moore EE, Good JT, Giansiracusa R. Peritoneovenous shunt in the management of the hepatorenal syndrome. Kidney Int 1986;30:736–740.CrossRefGoogle Scholar
  96. 96.
    Wood RP, Ellis D, Starzl T. The reversal of the hepatorenal syndrome in four pediatric patients following successful orthotopic liver transplantation. Ann Surg 1987;205:415–419.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • L. M. Blendis
    • 1
  1. 1.Department of Medicine, Toronto General HospitalUniversity of TorontoTorontoCanada

Personalised recommendations